Lucia Bortot

Udine, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Prognostic and predictive value of HRD in early triple negative breast cancer (TNBC).

Prognostic and predictive value of HRD in early triple negative breast cancer (TNBC).

Journal: Critical reviews in oncology/hematology

Published: August 07, 2025

Epigenetic and fragment-based profiling across CDK4/6 inhibitors in first-line HR+/HER2- metastatic breast cancer. An ancillary analysis of the MAGNETIC.1 study.

Epigenetic and fragment-based profiling across CDK4/6 inhibitors in first-line HR+/HER2- metastatic breast cancer. An ancillary analysis of the MAGNETIC.1 study.

Journal: Breast (Edinburgh, Scotland)

Published: June 24, 2025

CDK4/6 Inhibitors as Upfront Treatment in a Patient with Breast Cancer Presenting with a Clinical Critic Situation: A Case Report and Review of the Literature.

CDK4/6 Inhibitors as Upfront Treatment in a Patient with Breast Cancer Presenting with a Clinical Critic Situation: A Case Report and Review of the Literature.

Journal: Current oncology (Toronto, Ont.)

Published: November 03, 2022

Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?

Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?

Journal: Frontiers in oncology

Published: February 28, 2022

Histological patterns and intra-tumor heterogeneity as prognostication tools in high grade serous ovarian cancers.

Histological patterns and intra-tumor heterogeneity as prognostication tools in high grade serous ovarian cancers.

Journal: Gynecologic oncology

Published: January 25, 2021

Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva.

Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 19, 2020

Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis.

Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis.

Journal: International journal of molecular sciences

Published: April 23, 2020

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer.

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer.

Journal: Frontiers in oncology

Published: April 08, 2020

Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study.

Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study.

Journal: Clinical nutrition (Edinburgh, Scotland)

Published: January 03, 2020

Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker.

Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker.

Journal: Cancers

Published: July 09, 2019

Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside.

Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside.

Journal: Cancers

Published: May 14, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026